Articles tagged "Liver"

2020 American Transplant Congress
The Link between Waitlist Mortality and Access to Transplant, an Imaginative Reality
R. Batra¹, D. Mulligan¹, D. Haakinson¹, S. Noreen², D. Stewart², G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Liver transplant waitlist mortality due to inadequate access to livers is the Achilles heel in liver transplantation in United States. This remains amongst the…
2020 American Transplant Congress
The Effect of Expanding Utilization of Living Donor Liver Transplantation tn the United States
K. N. Wanis¹, A. Sarvet¹, M. J. Stensrud¹, B. Al-Judaibi², K. Tomiyama³, R. Hernandez-Alejandro³
¹Epidemiology, Harvard School of Public Health, Boston, MA, ²Division of Transplantation, University of Rochester, Rochester, NY, ³Division of Transplantation/Hepatobiliary Surgery, Department of Surgery, University of Rochester, Rochester, NY
*Purpose: We estimated the effect that expansion of living donor liver transplantation (LDLT) would have on mortality for individuals added to the waitlist.*Methods: Using data…
2020 American Transplant Congress
A Single-Center Experience in Transfusion-Free Liver Transplantation: Referrals and Outcomes from 2005 to 2019
B. H. Horwich¹, A. Mulgaonkar¹, B. Kim², N. Kaur¹, J. Kahn², Y. Genyk³, A. Ahearn³, H. Han²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²GI & Liver Diseases, University of Southern California, Los Angeles, CA, ³Surgery, University of Southern California, Los Angeles, CA
*Purpose: The Jehovah’s Witnesses is a religious group known to the medical community for its non-acceptance of blood products. This poses a significant challenge in…
2020 American Transplant Congress
Development and Characterization of Decellularized Whole Human Livers for Increasing Donor Pool
A. Acun, R. Oganesyan, B. E. Uygun
Massachusetts General Hospital - Harvard Medical School, Boston, MA
*Purpose: Liver diseases are recognized as the second leading cause of mortality amongst all digestive diseases in the United States. Orthotopic liver transplantation leads to…
2020 American Transplant Congress
Transplant Surgery Continuing Professional Development Courses Increase Knowledge and Procedural Confidence
M. J. Hobeika¹, T. Menser², A. Kassam³, T. C. Rice⁴, T. S. Diwan³
¹Houston Methodist Hospital, Houston, TX, ²Houston Methodist Research Institute, Houston, TX, ³University of Cincinnati Medical Center, Cincinnati, OH, ⁴Washington University, St. Louis, MO
*Purpose: Continuing professional development (CPD) workshops are emerging to fill critical knowledge and skill gaps in both surgical trainees and practicing surgeons. The ASTS has…
2020 American Transplant Congress
A Comparison of Temporal Gene Expression Patterns in Kidney, Heart, Liver, and Lung Transplant Biopsies
P. Halloran¹, J. Reeve¹, .. the INTERLUNG Study Group², .. the INTERHEART Study Group², .. the INTERLIVER Study Group², &. the INTERCOMEX Study Group²
¹University of Alberta, Edmonton, AB, Canada, ²., ., AB, Canada
*Purpose: Gene expression patterns change with time post-transplant. The MMDx system makes it possible to do cross-organ comparisons using the same microarray platform and gene…
2020 American Transplant Congress
Long-Term Metabolic Control and Health Outcomes in Maple Syrup Urine Disease Following Liver Transplantation in Children and Young Adults
C. Ewing¹, K. Soltys², K. Strauss³, G. Mazariegos², R. Sindhi², J. Vockley², P. McKiernan², R. Squires², G. Bond², A. Khanna², J. Squires²
¹School of Medicine, University of Pittsburgh, Pittsburgh, PA, ²Children's Hospital of Pittsburgh, Pittsburgh, PA, ³Clinic for Special Children, Strausburg, PA
*Purpose: Determine outcomes and branch-chain amino acid (BCAA - leucine [LEU], isoleucine [ISO], and valine [VAL]) levels at 1-3, 4-7, and 8-10 years for patient’s…
2020 American Transplant Congress
Waitlist Mortality and Transplant Probability for Inactively Listed Liver Patients Depends on Donor Service Areas’ Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart², D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Presently, the outcome of patients listed inactive on liver transplant waiting list (WL) are unknown; as inactive patients cannot receive deceased donor organ offers,…
2020 American Transplant Congress
Has Every Possible Life Been Saved?: Rummaging Through the Discard Heap
A. L. Friedman, E. Marquez
LiveOnNY, NY, NY
*Purpose: To determine the reasons that deceased donor organs were allocated but not transplanted (TXP) in a large organ procurement organization (OPO).*Methods: All organs allocated…
2020 American Transplant Congress
Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation
E. Palte¹, J. Duong², H. Remotti³, J. Burt³, A. Griesemer⁴, B. Samstein⁵, D. Marratta⁶, A. N. Fox⁷
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Columbia University Mailman School of Public Health, New York, NY, ³Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY, ⁵Department of Surgery, Weill Cornell Medicine, New York, NY, ⁶Department of Medicine, Columbia University, New York, NY, ⁷Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY
*Purpose: Living donor liver transplantation (LDLT) increases the donor pool and affords a life-saving cure to recipients who do not have MELD-based access to allografts.…